Free companion page

Companion page: How to Read a Biopharma Manufacturing and Supply Agreement

The forty-question reading checklist from Appendix B, free to print and use on a real agreement.

This page is free and needs no sign-up. It reproduces material from How to Read a Biopharma Manufacturing and Supply Agreement by Julian R. Sterling so you can print it or keep it open while you work.

To print it, use your browser's print button. Figures are as stated in the book; check the official source before relying on any of them.

Appendix B: The Reading Checklist: Forty Questions for Any Manufacturing and Supply Agreement

Use these questions on any manufacturing and supply agreement and on the quality agreement that goes with it. Each item has one line to ask and one sentence on why it matters. The groups follow the chapters of this book, which explain the rules and show them on the case.

Architecture and the Quality Agreement (Chapter 1)

  1. Is there a separate quality agreement, and is it signed before any batch is made under current good manufacturing practice? Why it matters: the commercial paper alone does not show who decides release, deviations and records.
  2. Which document prevails in a conflict, and does the rule depend on the subject? Why it matters: a single ranking can send a pricing dispute to a quality document, or the reverse.
  3. Who exactly are the parties, and does the owner contract with the manufacturer's operating company or with a parent? Why it matters: the entity that signs is the entity that can be held to the promises, and affiliates may do part of the work.
  4. Which steps does the manufacturer perform, and which stay with other firms, such as the fill-finish contractor? Why it matters: a reader who assumes one firm covers every step can miss the gap between two contractors.
  5. Which attachments carry the real terms: the project plan, the specifications, the price schedule, the forecast form? Why it matters: a main body that points to schedules often leaves the numbers that matter in the schedules.
  6. Which party holds the marketing application and decides every filing? Why it matters: the answer fixes who answers the FDA and who controls any change that must be filed.

Scope and Technology Transfer (Chapter 2)

  1. Does the scope name the product, the process and the site, and does it limit the manufacturer to that scope? Why it matters: vague scope leaves room for argument about extra work and extra fees.
  2. What must the owner deliver under the project plan, and by when? Why it matters: late inputs from the owner can excuse late work by the manufacturer.
  3. How are transfer fees tied to events, and does each payment fall after its event? Why it matters: a payment that comes before its event leaves the owner paying for work not yet done.
  4. What happens when the manufacturer is late on a transfer step: a credit, a cap, a termination right or nothing? Why it matters: the delay clause is often the only price put on lost time.

Forecasts and Minimums (Chapter 3)

  1. How long is the rolling forecast, and which months bind? Why it matters: the binding window sets how much demand risk the owner carries.
  2. Is a cancelled firm order paid in full, in part or not at all? Why it matters: that one line fixes the cost of changing course.
  3. In the middle months, how far may the forecast move, and from which base? Why it matters: a band measured against the wrong base can be wider or narrower than it looks.
  4. Must the manufacturer accept orders above the binding quantity, and up to what level? Why it matters: without an acceptance level, a product that grows faster than planned can outrun the capacity it needs.
  5. Is the minimum measured on batches ordered, delivered or paid for? Why it matters: the measure decides whether delays on either side change the fee.
  6. How is a shortfall fee calculated and invoiced, and does any capacity reservation fee credit against later invoices? Why it matters: fees can overlap, and a credit can be lost if it is not used by its date.

Price (Chapter 4)

  1. Is the price per batch or per unit of product, and what yield is assumed behind it? Why it matters: the unit of price decides who carries a batch that yields little.
  2. What does the price include, and which part is a raw materials budget and which part is conversion cost? Why it matters: splitting the price shows what can move and what cannot.
  3. How does the price adjust each year: which index, what cap and what notice? Why it matters: an unnamed index, or one with no cap, leaves the adjustment open to argument.
  4. Do raw materials pass through, above what band, and with what proof? Why it matters: a pass-through rule can stack on top of an index and raise the price twice for the same cost.
  5. Is there a low-yield rule, such as pro rata pricing below a guaranteed minimum? Why it matters: without it, a batch that conforms but yields little is still invoiced at the full price.

Release, Deviations and Change Control (Chapter 5)

  1. Who issues the certificate of analysis and the certificate of compliance, and how soon after the batch ends? Why it matters: these documents start the owner's release clock.
  2. Who decides final release, within what time, and what follows if the owner is silent? Why it matters: an open-ended review leaves finished product waiting in storage.
  3. How fast must the manufacturer report critical deviations and major deviations? Why it matters: a late report removes the owner's chance to act on a problem that may reach patients.
  4. How long may an investigation run, and who may extend it? Why it matters: investigation time is also payment time and supply time.
  5. Which changes need the owner's prior written approval, and which need only notice? Why it matters: a change to the filed process or to a supplier can require a filing, so the line must be drawn with care.

Failed Batches (Chapter 6)

  1. How is a failed batch defined, and against which specification? Why it matters: the definition decides which results start the failed batch clause.
  2. Who pays when the cause is the manufacturer, the owner or no assignable cause? Why it matters: the cause rule is the money rule.
  3. Is replacement or refund the owner's remedy, is it the sole remedy, and what time limit applies? Why it matters: a sole remedy can bar a claim for other losses from the same batch.
  4. How are disagreements on conformity settled, and who pays the neutral laboratory? Why it matters: a neutral test is quick only if the clause says how it is chosen and whether its result binds.

Supply Assurance (Chapter 7)

  1. Who holds a safety stock, where is it stored, and who bears the cost of carrying it? Why it matters: stock is cash tied up, and it sits at the same site that may fail.
  2. Is there a back-up manufacturer right, what triggers it, and what happens to the minimum? Why it matters: a trigger that cannot realistically be met gives no protection, and a minimum that stays full punishes the move.
  3. What does the owner receive on a move: a transfer package, a know-how license, support? Why it matters: a right to documents without a right to know-how may leave the successor unable to start.

Improvements and Know-How (Chapter 8)

  1. Who owns improvements specific to the product, and who owns improvements to the manufacturer's platform? Why it matters: ownership decides who may use a better process after the contract ends.
  2. Does a gain from an improvement reach the owner, through the price or through the minimum? Why it matters: a yield gain can mean fewer batches without lowering a fixed minimum.

Inspections and Audits (Chapter 9)

  1. How quickly must the manufacturer tell the owner of an inspection notice, share written observations and let the owner comment on responses? Why it matters: the owner holds the application and is exposed to what the manufacturer tells an inspector.
  2. What audit rights does the owner have, routine and for cause, and how long are batch records kept? Why it matters: a right to audit is of little use without access to records.

Liability, Recall and Exit (Chapters 10 and 11)

  1. What is the liability cap, what is carved out of it, and are consequential damages excluded? Why it matters: the cap, the carve-outs and the exclusion together set the real exposure.
  2. Who bears recall costs, on what cause test, and what insurance backs the promise? Why it matters: a recall can cost more than a cap allows, and insurance shows who can pay.
  3. Can the owner terminate for convenience, on what notice, with what payments on exit, and what must the manufacturer deliver for transfer out? Why it matters: exit costs stay predictable only when the support, the materials and the timing are written down.